Skip to content
Home/Companies/Biotech/Cisbio

Cisbio

Biotech·France·Exited 2019·Held 3yr
Entry
2016
Hold
3yr
Exit
2019

Who owns Cisbio?

Cisbio was owned by Abénex through Abénex V (2017 vintage) from 2016 to 2019, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Abénex
Investor
Abénex
Abénex V · 2017 · Buyout

Key facts

HQFrance
SectorBiotech
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2019

More from Abénex V

Other portfolio companies in the same fund.

Ecole Supérieure de Comptabilité et de Gestion
Exited 2026
Business ServicesFrance· 2022
to
ADF Group
Exited 2024
LogisticsFrance· 2021
to
Europa Group
Europa Group
Exited 2024
Business ServicesFrance· 2021
to
Eurêka Education
Eurêka Education
Active
EducationFrance· 2020
Blanchon
Blanchon
Exited 2021
Real EstateFrance· 2019
to
AC Environnement
Active
ConstructionFrance· 2018

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Cisbio

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Cisbio?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Cisbio.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue